--- Query Results --- | |||
Organization: | Alberta Precision Laboratories | ||
Message Alert: | PLEASE NOTE: This Test Directory is in an interim state and due to changes pertaining to the DynaLIFE transition, performing site for routing has not been updated. Please refer to Laboratory Information System for appropriate routing. | ||
Test Name/Synonym: | Lyme Disease Serology (Synonym: Lyme Neuroborreliosis, Erythema Migrans, Borrelia burgdorferi, Borrelia burgdorferi Sensu Lato, Borrelia burgdorferi Sensu Stricto, Borrelia garinii, Borrelia afzelii) | ||
Pathogen: | Borrelia burgdorferi Borrelia afzelii Borrelia garinii | ||
Test Includes: | Serology | ||
LABID (Connect Care): | LAB788 | ||
Specimen Collection Requirements: | Adult: 5 mL GOLD SST Pediatric: 2 mL RED | ||
Test Resources: |
| ||
Method: | Sera collected within the first two weeks of acute onset of symptoms or at rash onset or if the patient is treated in this phase can result in negative serology. Repeat testing is indicated if the patient is untreated and clinical suspicion is high. | ||
Routine Turn Around Time: | 5 days | ||
Testing Area: | Virology | ||
Performing Site: | Provincial Laboratory for Public Health (Calgary and Edmonton) | ||
Additional Test Information: | The screening EIA detects antibodies to the three genospecies of Lyme disease; B. burgdorferi, afzelii and garinii. Sera that screen positive and equivocal are referred to the National Microbiology Laboratory for Western Blot confirmation. B. burgdorferi is only found in North America, hence travel history and/or residency outside of North America must be provided for testing to the European genospecies (B. afzelii and garinii) to be performed. | ||
Last Updated On: | Friday, July 19, 2024 | ||
Date of Last Review: | Jul 16 2024 12:00AM | ||